Latest Insider Transactions at Oncosec Medical Inc (ONCS)
This section provides a real-time view of insider transactions for Oncosec Medical Inc (ONCS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ONCOSEC MEDICAL Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ONCOSEC MEDICAL Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2023
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
40
-3.82%
|
$40
$1.37 P/Share
|
|
Nov 04
2022
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
283
-1.22%
|
$0
$0.37 P/Share
|
|
Aug 05
2022
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
284
-1.21%
|
$0
$0.71 P/Share
|
|
May 06
2022
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
274
-1.15%
|
$0
$0.83 P/Share
|
|
Feb 09
2022
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
409
-1.69%
|
$0
$0.88 P/Share
|
|
Nov 01
2021
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
343
-1.4%
|
$343
$1.75 P/Share
|
|
Aug 23
2021
|
Margaret Dalesandro Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$20,000
$1.89 P/Share
|
|
Aug 23
2021
|
Yuhang Zhao Director |
BUY
Open market or private purchase
|
Direct |
4,000
+25.0%
|
$4,000
$1.88 P/Share
|
|
Aug 20
2021
|
Yuhang Zhao Director |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$8,000
$1.94 P/Share
|
|
Aug 02
2021
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
412
-1.65%
|
$824
$2.18 P/Share
|
|
Jun 28
2021
|
Brian A Leuthner Interim CEO |
SELL
Open market or private sale
|
Direct |
13,613
-7.09%
|
$40,839
$3.16 P/Share
|
|
Jun 28
2021
|
Brian A Leuthner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
192,000
+50.0%
|
-
|
|
May 03
2021
|
Robert J Del Aversano VP, Finance |
SELL
Open market or private sale
|
Direct |
453
-1.78%
|
$1,812
$4.86 P/Share
|
|
Apr 30
2021
|
Daniel J. O'Connor CEO and President |
SELL
Open market or private sale
|
Direct |
3,172
-3.2%
|
$12,688
$4.86 P/Share
|
|
Apr 16
2021
|
China Grand Pharmaceutical & Healthcare Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,691,806
+7.74%
|
$5,075,418
$3.45 P/Share
|
|
Feb 18
2021
|
Alpha Holdings, Inc. Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
368,250
+17.65%
|
$1,104,750
$3.45 P/Share
|
|
Feb 01
2021
|
Robert J Del Aversano VP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+25.6%
|
-
|
|
Feb 01
2021
|
Daniel J. O'Connor CEO and President |
SELL
Open market or private sale
|
Direct |
3,413
-3.32%
|
$23,891
$7.71 P/Share
|
|
Jan 25
2021
|
China Grand Pharmaceutical & Healthcare Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,067,037
+18.05%
|
$20,335,185
$5.45 P/Share
|
|
Nov 20
2020
|
Alpha Holdings, Inc. Director |
SELL
Open market or private sale
|
Direct |
80,000
-5.59%
|
$320,000
$4.92 P/Share
|
|
Nov 19
2020
|
Alpha Holdings, Inc. Director |
SELL
Open market or private sale
|
Direct |
50,000
-3.38%
|
$250,000
$5.1 P/Share
|
|
Nov 18
2020
|
Alpha Holdings, Inc. Director |
SELL
Open market or private sale
|
Direct |
10,999
-0.74%
|
$54,995
$5.24 P/Share
|
|
Nov 18
2020
|
Alpha Holdings, Inc. Director |
SELL
Open market or private sale
|
Indirect |
40,000
-2.61%
|
$200,000
$5.24 P/Share
|
|
Nov 17
2020
|
Alpha Holdings, Inc. Director |
SELL
Open market or private sale
|
Indirect |
40,000
-2.55%
|
$200,000
$5.17 P/Share
|
|
Nov 16
2020
|
Alpha Holdings, Inc. Director |
SELL
Open market or private sale
|
Indirect |
40,000
-2.48%
|
$200,000
$5.41 P/Share
|
|
Nov 02
2020
|
Daniel J. O'Connor CEO and President |
SELL
Open market or private sale
|
Direct |
3,280
-3.1%
|
$9,840
$3.79 P/Share
|